Updated

CNBC's Jim Cramer highlighted Merck as his preferred defensive stock pick, citing the pharmaceutical company's stability and dividend characteristics amid broader market uncertainty. The commentary reflects continued investor interest in defensive positioning within health care as markets weigh risks tied to interest rates and geopolitical developments.